Skip to main content
Focused investors/Seth Klarman

Seth Klarman - Baupost Group

As of Q2 2026, Seth Klarman reported 23 long-equity positions worth $5.42B in aggregate.

Copy-investor backtest

Latest quarter
+3.22%
1-year
+20.94%
3-year
+48.31%
5-year
+12.01%
3-year vs S&P 500
-25.70%
5-year vs S&P 500
-61.90%
5-year top 5
-0.29%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when Seth Klarman files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 12 of 39 rows. Rows without a quote are marked unavailable.

1FOXATWENTY FIRST CENTY FOX INC17.64%Add +48.2%39,415,829$1.96B$49.69No quote
2SYFSYNCHRONY FINL8.81%-29,295,030$977.87M$33.38No quote
3LNGCHENIERE ENERGY INC8.34%Reduce -31.5%14,196,135$925.45MNo quoteNo quote
4VSATVIASAT INC8.13%Add +0.5%13,732,068$902.47M$65.72No quote
5QRVOQORVO INC7.94%-11,000,000$881.87M$80.17No quote
6AGNALLERGAN PLC7.43%Add +4.2%4,950,000$825.26MNo quoteNo quote
7PXDPIONEER NAT RES CO6.82%-4,000,000$756.96MNo quoteNo quote
8FOXTWENTY FIRST CENTY FOX INC6.04%Add +19.0%13,606,260$670.38M$49.27No quote
9ARANTERO RES CORP5.11%-26,587,791$567.65M$21.35No quote
10CLNYCOLONY CAP INC NEW2.79%New49,687,370$310.05MNo quoteNo quote
11TAT&T INC2.74%New9,480,700$304.43M$32.11No quote
12CAHCARDINAL HEALTH INC2.24%-5,100,000$249.03M$48.83No quote
13ATRAATARA BIOTHERAPEUTICS INC2.07%-6,254,632$229.86MNo quoteNo quote
14MCKMCKESSON CORP1.96%Add +0.7%1,627,700$217.14M$133.40No quote
15TBPHTHERAVANCE BIOPHARMA INC1.90%-9,309,168$211.13MNo quoteNo quote
16PCGPG&E CORP1.73%Add +42.9%4,500,000$191.52M$42.56No quote
17CORAMERISOURCEBERGEN CORP1.44%Add +42.2%1,873,565$159.76MNo quoteNo quote
18VRTVVERITIV CORP1.37%-3,824,385$152.4MNo quoteNo quote
19TRCOTRIBUNE MEDIA CO1.03%New2,996,042$114.66MNo quoteNo quote
20KERXKERYX BIOPHARMACEUTICALS INC0.87%-25,791,678$96.98MNo quoteNo quote
21SBGISINCLAIR BROADCAST GROUP INC0.74%New2,571,302$82.67M$32.15No quote
22AMCAMC ENTMT HLDGS INC0.72%-5,000,000$79.5MNo quoteNo quote
23NGNOVAGOLD RES INC0.54%-13,467,145$59.93M$4.45No quote
24GTYHUGTY TECHNOLOGY HOLDINGS INC0.41%-4,400,000$45.89MNo quoteNo quote
25PRTKPARATEK PHARMACEUTICALS INC0.22%-2,394,498$24.42MNo quoteNo quote
26TBIOTRANSLATE BIO INC0.22%New1,923,076$24.33MNo quoteNo quote
27SCACSABAN CAP ACQUISITION CORP0.21%-2,326,500$23.45MNo quoteNo quote
28TMQTRILOGY METALS INC NEW0.21%Add +23.1%13,050,758$23.17MNo quoteNo quote
29SHPGSHIRE PLC0.15%New98,932$16.7MNo quoteNo quote
30STNLUSENTINEL ENERGY SVCS INC0.15%-1,600,000$16.14MNo quoteNo quote
31SCACWSABAN CAP ACQUISITION CORP0.01%-1,163,250$1.4MNo quoteNo quote
37TWXTIME WARNER INC-Sold0$0No quoteNo quote
36PBFPBF ENERGY INC-Sold0$0No quoteNo quote
35OREXOREXIGEN THERAPEUTICS INC-Sold0$0No quoteNo quote
34FWPFORWARD PHARMA A/S-Sold0$0No quoteNo quote
33CLNSCOLONY NORTHSTAR INC-Sold0$0No quoteNo quote
32IMOSCHIPMOS TECHNOLOGIES INC-Sold0$0No quoteNo quote

Other instruments

Bonds, warrants, or non-share principal positions reported alongside the equity portfolio.

1TSLA 2.375 03/15/22TESLA INCNOTE 2.375% 3/1OTHER250,000,000$306.25M
2TBPH 3.25 11/01/23THERAVANCE BIOPHARMA INCNOTE 3.250%11/0OTHER30,000,000$29.96M